Scroll News
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
  • Tech
    • App News
    • Gadgets
  • Auto
  • Others
    • Sports
    • Agriculture
    • Science
    • Astrology
    • Finance/Money
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
  • Tech
    • App News
    • Gadgets
  • Auto
  • Others
    • Sports
    • Agriculture
    • Science
    • Astrology
    • Finance/Money
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
Scroll News
No Result
View All Result
Home Lifestyle Health & Fitness

First mRNA-based COVID 19 vaccine gets nod for phase II/III trial

Scroll News by Scroll News
August 25, 2021
in Health & Fitness, National
0
Share on FacebookShare on Twitter

New Delhi: The fight against the ongoing epidemic of COVID-19 is all set to get stronger. The office of the Drug Controller General of India has approved a proposal of the Pune-based Gennova Biopharmaceuticals Ltd., to go in for phase II / III trial of the country’s first mRNA-based vaccine for COVID-19 called HGCO19.

The company had submitted the interim clinical data of the Phase I study to the Central Drugs Standard Control Organisation (CDSCO), the Government of India’s National Regulatory Authority (NRA). The Vaccine Subject Expert Committee (SEC) reviewed the data and found that the vaccine was safe, tolerable, and immunogenic in the participants of the study.

You May Also Like This

Stem Cell Banking Emerges as a Vital Safeguard Against Life-Threatening Diseases; Experts Call for Increasing Awareness

Stem Cell Banking Emerges as a Vital Safeguard Against Life-Threatening Diseases; Experts Call for Increasing Awareness

September 10, 2025
India’s Dengue Hotspots: PharmEasy Report Shows Karnataka, Tamil Nadu, and Maharashtra Leading the Charts

India’s Dengue Hotspots: PharmEasy Report Shows Karnataka, Tamil Nadu, and Maharashtra Leading the Charts

August 29, 2025
Kalmykia Delegation Arrived  in India, Boosting Cultural and Spiritual Cooperation

Kalmykia Delegation Arrived  in India, Boosting Cultural and Spiritual Cooperation

August 28, 2025

Consequently, the proposal for Phase II and Phase III study for “A prospective, multicentre, randomized, active-controlled, observer-blind, phase II study seamlessly followed by a phase III study to evaluate the safety, tolerability, and immunogenicity of the candidate HGCO19 (covid-19 vaccine) in healthy subjects” was submitted that has now been approved.

The study will be conducted within India in 10-15 sites in Phase II and 22-27 sites in Phase III. Gennova plans to use the DBT-ICMR clinical trial network sites for this study.

The vaccine development program was partly funded by the Department of Biotechnology (DBT), Govt. of India under Ind CEPI, in June 2020. Later on, the DBT further supported the program under the Mission COVID Suraksha – The Indian COVID-19 Vaccine Development Mission, implemented by BIRAC.

“It is a matter of great pride that Nation’s first mRNA-based vaccine is found to be safe and the Drugs Controller General of India DCG(I) has approved Phase II/III trial. We are confident that this will be an important vaccine for both India and the world. This is an important milestone in our Indigenous Vaccine Development Mission and positions India on the Global Map for Novel Vaccine Development,” said Dr.RenuSwarup, Secretary, DBT, and Chairperson, Biotechnology Industry Research Assistance Council (BIRAC).

Dr. Sanjay Singh, CEO of Gennova Biopharmaceuticals Ltd., said that “After establishing the safety of our mRNA-based COVID-19 vaccine candidate HGCO19 in Phase I clinical trial, Gennova’s focus is to start Phase II/III pivotal clinical trial. In parallel, Gennova is investing in scaling up its manufacturing capacity to cater to the nation’s vaccine requirement”. (India Science Wire)

Tags: CDSCOCentral Drugs Standard Control OrganisationCOVID SurakshaDBTDCG (I)Department of BiotechnologyDrug Controller General of IndiaGennova Biopharmaceuticals Ltd.immunogenicityInd CEPImRNAPunesafetytolerabilityvaccine
ShareTweetShareShareSendSend
Previous Post

Ogo Nirupama actress Arkoja Acharyya celebrates Rakshabandhan with renowned singer and producer Sarbajit Ghosh through upcoming calendar photoshoot

Next Post

Government incentive in offing for 75 start-ups in telemedicine, artificial intelligence, and digital health

Related Posts

Stem Cell Banking Emerges as a Vital Safeguard Against Life-Threatening Diseases; Experts Call for Increasing Awareness
Health & Fitness

Stem Cell Banking Emerges as a Vital Safeguard Against Life-Threatening Diseases; Experts Call for Increasing Awareness

September 10, 2025
India’s Dengue Hotspots: PharmEasy Report Shows Karnataka, Tamil Nadu, and Maharashtra Leading the Charts
Health & Fitness

India’s Dengue Hotspots: PharmEasy Report Shows Karnataka, Tamil Nadu, and Maharashtra Leading the Charts

August 29, 2025
Kalmykia Delegation Arrived  in India, Boosting Cultural and Spiritual Cooperation
National

Kalmykia Delegation Arrived  in India, Boosting Cultural and Spiritual Cooperation

August 28, 2025
Redefining Fitness In India: Siraj Lalani’s Vision With Plus Fitness 
Health & Fitness

Redefining Fitness In India: Siraj Lalani’s Vision With Plus Fitness 

August 13, 2025
Robotic-Assisted Breast Surgery: A New Era in Cancer Care- Dr. Sandeep Nayak
Health & Fitness

Robotic-Assisted Breast Surgery: A New Era in Cancer Care- Dr. Sandeep Nayak

July 31, 2025
The Science of Thicker Hair: Why Combining Bio-FUE with GFC Is Redefining Hair Restoration
Health & Fitness

The Science of Thicker Hair: Why Combining Bio-FUE with GFC Is Redefining Hair Restoration

July 24, 2025
Next Post

Government incentive in offing for 75 start-ups in telemedicine, artificial intelligence, and digital health

Niti Vakharia Kharwar from Nits saloon was honoured by One Step Charitable Trust as “Real Heroes of Surat”

"When you dream big, you got to work just as hard." says Pardeep Singh Toor

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Ground work yet to be started at Odisha coal mines

4 years ago
It’s hard not to fall in love with Kashika Kapoor after watching her in RATHWOFIVE & Neeti Mohan’s ‘Sacha Wala Pyar’

It’s hard not to fall in love with Kashika Kapoor after watching her in RATHWOFIVE & Neeti Mohan’s ‘Sacha Wala Pyar’

3 years ago
The Ranch’ organizes a highly successful Homeland Chandigarh Horse Show

The Ranch’ organizes a highly successful Homeland Chandigarh Horse Show

3 years ago

IIT Delhi to establish department of energy science and engineering

4 years ago

Categories

  • Agriculture
  • App News
  • Astrology
  • Auto
  • Business
  • Education
  • Entertainment
  • Fashion & Beauty
  • Finance/Money
  • Food
  • Gadgets
  • Health & Fitness
  • Lifestyle
  • National
  • Photography
  • Politics
  • Press Release
  • Religion
  • Science
  • Social Work
  • Sports
  • State News
  • Tech
  • Travel
  • World

Topics

Ace Entrepreneur actor Artificial intelligence Bangalore Bengaluru Blockchain technology BRICS CCI Content Creator COVID-19 Cryptocurrency CSIR DBT Delhi Digital Marketing digital marketing agency DST Dubai Education entrepreneur entrepreneurship Fairplay Gujarat Gurugram Hyderabad IIT Delhi India Indian Institute of Technology Influencer Influencerquipo innovation Kingston Technology K Raheja Corp Homes memory products and technology solutions Mumbai Music Industry pandemic photography producer Pune real estate research Shan Se Entertainment Shantanu Bhamare social media Surat
No Result
View All Result

Highlights

Stem Cell Banking Emerges as a Vital Safeguard Against Life-Threatening Diseases; Experts Call for Increasing Awareness

Exhibition of Russian Art Masterpieces Dedicated to Moscow Opens at VDNH

Breaking the Monotony: How NoMoreType is Redefining Digital Lifestyle Shopping

From Flood Ruins to Global Recognition: Vilvex Cables’ Remarkable CE Marking Achievement

India’s First Nanobubble Pioneer: How Prasinos Made World-Class Technology Affordable for Everyone

Onlive Server Rolls Out Premium 10 Gbps France Dedicated Server Plans with No Setup Fees

Trending

Courtyard Mahabaleshwar, Marriott Bonvoy, Courtyard by Marriott Mahabaleshwar,
Lifestyle

Turn Every Stay into More with Marriott Bonvoy at Courtyard Mahabaleshwar 

by Scroll News
September 11, 2025
0

Mahabaleshwar, (Maharashtra) 11th September 2025: This season, Courtyard by Marriott Mahabaleshwar gives you yet another reason to plan your...

Kustard Technologies Appoints Madhu Kiran Ganti as CEO to Spearhead AI-Powered Growth

Kustard Technologies Appoints Madhu Kiran Ganti as CEO to Spearhead AI-Powered Growth

September 10, 2025
TeacherJob.in: 19-Year-Old Indresh Arora Redefines Teacher Recruitment in India

TeacherJob.in: 19-Year-Old Indresh Arora Redefines Teacher Recruitment in India

September 10, 2025
Stem Cell Banking Emerges as a Vital Safeguard Against Life-Threatening Diseases; Experts Call for Increasing Awareness

Stem Cell Banking Emerges as a Vital Safeguard Against Life-Threatening Diseases; Experts Call for Increasing Awareness

September 10, 2025
Exhibition of Russian Art Masterpieces Dedicated to Moscow Opens at VDNH

Exhibition of Russian Art Masterpieces Dedicated to Moscow Opens at VDNH

September 10, 2025
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News

© 2022 Scroll News

No Result
View All Result
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Home
  • Privacy Policy

© 2022 Scroll News